PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER

Clinical trials for PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER explained in plain language.

Never miss a new study

Get alerted when new PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER trials appear

Sign up with your email to follow new studies for PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo takes aim at Treatment-Resistant prostate cancer

Disease control Recruiting now

This study is testing whether a new combination of two drugs, tulmimetostat and JSB462, is safe and works better than current standard treatments for advanced prostate cancer that has spread and stopped responding to hormone therapy. The first part of the study will find the safe…

Matched conditions: PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER

Get alerted when new PROGRESSIVE METASTATIC CASTRATE RESISTANT PROSTATE CANCER trials appear

New drug duo takes aim at Treatment-Resistant prostate cancer